Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The RasGAP SH3 domain binding proteins (G3BPs) are a highly conserved family of multi-functional RNA binding proteins. Recently, accumulating evidence has indicated that G3BPs play predominant roles in controlling critical cellular processes that include growth, proliferation and apoptosis. The G3BP family includes two members in mammals, ie, G3BP1 and G3BP2. G3BP1 knockout mice exhibit growth retardation, embryonic lethality and increased apoptotic cell death. Conversely, the overexpression of G3BP1 has been shown to induce S-phase entry with elevated cell proliferation. The G3BP1 protein is upregulated in a diversity of tumors and may present a novel target for cancer therapy. So far, the mechanisms by which G3BP1 executes its functions remain obscure, but prior studies have implicated G3BP1 in the modulation of RNA metabolism, Ras signaling, and the ubiquitin proteasome pathway.
G3BP1 and innate immune antiviral responses
Stress granules (SGs) are cytoplasmic storage sites containing translationally silenced mRNAs which can be released to resume translation after stress subsides. G3BP1 is extremely important for SG assembly. Depletion of G3BP1 inhibits SG formation in response to several stressors, and overexpression of G3BP1 nucleates SG formation independent of additional stressors. It reported that large G3BP1-induced SGs, but not small granules, are capable of triggering eIF2α phosphorylation through PKR, resulting in translational repression. Together with data indicating G3BP1 is targeted by many viruses, these properties suggested that G3BP1 is an antiviral protein important in innate immunity. The studies show that G3BP1 is an antiviral protein that activates the transcriptional arm of the innate immune response by NFκB and JNK transcription, and release of certain cytokines. G3BP1 is also involved in recruitment and activation of PKR at SGs, indicating G3BP1 regulates protein synthesis through PKR as part of a broad innate immune response. Strikingly, close proximity of G3BP1 and PKR within cells coincides with PKR activation, and the G3BP1 PxxP domain is required for PKR activation and antiviral activity of G3BP1. These data indicate that G3BP1 mediates crosstalk between stress responses and innate immunity and is an antiviral protein itself.
G3BP1 and Cancer
G3BP1 is known to contain an RNA recognition motif (RRM) by which exerts its mRNA-stabilizing or mRNA-degrading effects. The dysregulation of G3BP1 interactions with its target mRNAs may result in cancer development and progression. Some cancer-related gene, such as CTNNB1, c-MYC, and PMP22, have been implicated in the regulation of G3BP1 in this way. In human sarcomas, lung cancer, gastric cancer, colon cancer and breast cancer, G3BP1 has been found to be highly expressed. High expression of G3BP1 can promote the proliferation and motility of gastric cancer or breast cancer cells. Downregulation of G3BP1 in sarcoma xenografts prevented tumor invasion and completely blocked lung metastasis in mouse models. By binding with p53, G3BP1 led to the redistribution of p53 from the nucleus to the cytoplasm and affected cell apoptosis. These reports suggest the vital roles of G3BP1 in tumorigenesis.
Recently, researchers investigated the expression and functional role of G3BP1 in hepatocellular carcinoma (HCC). They found that G3BP1 was frequently upregulated in HCC samples and upregulated G3BP1 expression was correlated with poor survival. Further cell biological results indicated that G3BP1 promoted HCC cell migration and Slug protein was identified as one of the main effectors of G3BP1. Therefore, the study provides new insights into the role of G3BP1 in tumor and suggests that G3BP1 may be a potential target for HCC treatment.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.